Institution
Case Western Reserve University
Education•Cleveland, Ohio, United States•
About: Case Western Reserve University is a education organization based out in Cleveland, Ohio, United States. It is known for research contribution in the topics: Population & Health care. The organization has 54617 authors who have published 106568 publications receiving 5071613 citations. The organization is also known as: Case & Case Western.
Topics: Population, Health care, Cancer, Transplantation, Poison control
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Angiotensin-converting enzyme inhibitors appear to be more effective than beta-blockers or dihydropyridine calcium channel blockers in slowing GFR decline in hypertension.
Abstract: ContextHypertension is a leading cause of end-stage renal disease (ESRD) in
the United States, with no known treatment to prevent progressive declines
leading to ESRD.ObjectiveTo compare the effects of 2 levels of blood pressure (BP) control and
3 antihypertensive drug classes on glomerular filtration rate (GFR) decline
in hypertension.DesignRandomized 3 × 2 factorial trial with enrollment from February
1995 to September 1998.Setting and ParticipantsA total of 1094 African Americans aged 18 to 70 years with hypertensive
renal disease (GFR, 20-65 mL/min per 1.73 m2) were recruited from
21 clinical centers throughout the United States and followed up for 3 to
6.4 years.InterventionsParticipants were randomly assigned to 1 of 2 mean arterial pressure
goals, 102 to 107 mm Hg (usual; n = 554) or 92 mm Hg or less (lower; n = 540),
and to initial treatment with either a β-blocker (metoprolol 50-200 mg/d;
n = 441), an angiotensin-converting enzyme inhibitor (ramipril 2.5-10 mg/d;
n = 436) or a dihydropyridine calcium channel blocker, (amlodipine 5-10 mg/d;
n = 217). Open-label agents were added to achieve the assigned BP goals.Main Outcome MeasuresRate of change in GFR (GFR slope); clinical composite outcome of reduction
in GFR by 50% or more (or ≥25 mL/min per 1.73 m2) from baseline,
ESRD, or death. Three primary treatment comparisons were specified: lower
vs usual BP goal; ramipril vs metoprolol; and amlodipine vs metoprolol.ResultsAchieved BP averaged (SD) 128/78 (12/8) mm Hg in the lower BP group
and 141/85 (12/7) mm Hg in the usual BP group. The mean (SE) GFR slope from
baseline through 4 years did not differ significantly between the lower BP
group (−2.21 [0.17] mL/min per 1.73 m2 per year) and the
usual BP group (−1.95 [0.17] mL/min per 1.73 m2 per year; P = .24), and the lower BP goal did not significantly reduce
the rate of the clinical composite outcome (risk reduction for lower BP group
= 2%; 95% confidence interval [CI], −22% to 21%; P = .85). None of the drug group comparisons showed consistent significant
differences in the GFR slope. However, compared with the metoprolol and amlodipine
groups, the ramipril group manifested risk reductions in the clinical composite
outcome of 22% (95% CI, 1%-38%; P = .04) and 38%
(95% CI, 14%-56%; P = .004), respectively. There
was no significant difference in the clinical composite outcome between the
amlodipine and metoprolol groups.ConclusionsNo additional benefit of slowing progression of hypertensive nephrosclerosis
was observed with the lower BP goal. Angiotensin-converting enzyme inhibitors
appear to be more effective than β-blockers or dihydropyridine calcium
channel blockers in slowing GFR decline.
1,912 citations
••
TL;DR: Four-dimensional covariant nonlinear theories of massive gravity are constructed which are ghost-free in the decoupling limit to all orders, and the Hamiltonian constraint is maintained at least up to and including quartic order in nonlinearities, hence excluding the possibility of the Boulware-Deser ghost up to this order.
Abstract: We construct four-dimensional covariant nonlinear theories of massive gravity which are ghost-free in the decoupling limit to all orders. These theories resum explicitly all the nonlinear terms of an effective field theory of massive gravity. We show that away from the decoupling limit the Hamiltonian constraint is maintained at least up to and including quartic order in nonlinearities, hence excluding the possibility of the Boulware-Deser ghost up to this order. We also show that the same remains true to all orders in a similar toy model.
1,909 citations
••
TL;DR: A genome-wide association meta-analysis of individuals with clinically assessed or self-reported depression identifies 44 independent and significant loci and finds important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia.
Abstract: Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.
1,898 citations
••
United States Public Health Service1, Emory University2, Rutgers University3, Harvard University4, Central Michigan University5, Westchester Medical Center6, Icahn School of Medicine at Mount Sinai7, New York University8, Saint Barnabas Medical Center9, University of Pennsylvania10, SUNY Downstate Medical Center11, Yale University12, University of Colorado Denver13, Boston Children's Hospital14, Case Western Reserve University15, Louisiana State University16, University of Washington17, Johns Hopkins University18, University of Texas Health Science Center at Houston19, University of Mississippi20, Tufts University21, Vanderbilt University22
TL;DR: Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents.
Abstract: Background Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19)...
1,887 citations
••
TL;DR: The biological basis for the in vivo functioning of MSCs through development and aging is summarized and they appear to be valuable mediators for tissue repair and regeneration.
Abstract: Adult mesenchymal stem cells (MSCs) can be isolated from bone marrow or marrow aspirates and because they are culture-dish adherent, they can be expanded in culture while maintaining their multipotency. The MSCs have been used in preclinical models for tissue engineering of bone, cartilage, muscle, marrow stroma, tendon, fat, and other connective tissues. These tissue-engineered materials show considerable promise for use in rebuilding damaged or diseased mesenchymal tissues. Unanticipated is the realization that the MSCs secrete a large spectrum of bioactive molecules. These molecules are immunosuppressive, especially for T-cells and, thus, allogeneic MSCs can be considered for therapeutic use. In this context, the secreted bioactive molecules provide a regenerative microenvironment for a variety of injured adult tissues to limit the area of damage and to mount a self-regulated regenerative response. This regenerative microenvironment is referred to as trophic activity and, therefore, MSCs appear to be valuable mediators for tissue repair and regeneration. The natural titers of MSCs that are drawn to sites of tissue injury can be augmented by allogeneic MSCs delivered via the bloodstream. Indeed, human clinical trials are now under way to use allogeneic MSCs for treatment of myocardial infarcts, graft-versus-host disease, Crohn's Disease, cartilage and meniscus repair, stroke, and spinal cord injury. This review summarizes the biological basis for the in vivo functioning of MSCs through development and aging.
1,886 citations
Authors
Showing all 54953 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert Langer | 281 | 2324 | 326306 |
Bert Vogelstein | 247 | 757 | 332094 |
Zhong Lin Wang | 245 | 2529 | 259003 |
John Q. Trojanowski | 226 | 1467 | 213948 |
Kenneth W. Kinzler | 215 | 640 | 243944 |
Peter Libby | 211 | 932 | 182724 |
David Baltimore | 203 | 876 | 162955 |
Carlo M. Croce | 198 | 1135 | 189007 |
Ronald Klein | 194 | 1305 | 149140 |
Eric J. Topol | 193 | 1373 | 151025 |
Paul M. Thompson | 183 | 2271 | 146736 |
Yusuke Nakamura | 179 | 2076 | 160313 |
Dennis J. Selkoe | 177 | 607 | 145825 |
David L. Kaplan | 177 | 1944 | 146082 |
Evan E. Eichler | 170 | 567 | 150409 |